Skip to main content
SpringerLink
Log in

Fibrinolytic shutdown after cardiopulmonary bypass surgery is caused by circulating cytokines during operation, accompanied by endothelial injury

  • Original Articles
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

It has been hypothesized that increased cytokines during cardiopulmonary bypass surgery cause postoperative fibrinolytic shutdown. To investigate the role of cytokines and to elucidate its mechanism, tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), plasminogen activator inhibitor-1 antigen (PAI-1 Ag), PAI-1 activity, and thrombomodulin in 16 patients undergoing elective cardiopulmonary bypass surgery were analyzed after induction of anesthesia, before and after cardiopulmonary bypass, and at the end of the operation. during surgery, TNF-α and LI-1β were detected in 44% and 63% of the cases, respectively. PAI-1 Ag (P<0.01), PAI-1 activity (P<0.001) and thrombomodulin (P<0.01) were significantly increased at the end of the operation. The patients were divided into two groups and examined: Group 1 with either cytokine detected (n=12); and group 2 without detection of cytokines (n=4). At the end of the operation, both PAI-1 Ag (P<0.05) and PAI-1 activity (P<0.01) were significantly increased in group 1 compared with group 2. In group 1, there was a significant positive correlation between thrombomodulin and PAI-1 Ag (r 2=0.117,P<0.05) and PAI-1 activity (r 2=0.124,P<0.05). In conclusion, TFN-α and IL-1β were released into the systemic circulation during cardiopulmonary bypass surgery, and this release may have been caused by vascular endothelial injury. These cytokines increased PAI-1 activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morrison DC, Ulevitch RJ (1978) The effects of bacterial endotoxins on host mediation. Am J Pathol 93:527–617

    Google Scholar 

  2. Colluci M, P⇘ramo JA, Collen D (1985) Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 75:818–824

    Google Scholar 

  3. Schleef RR, Loskutoff DJ (1988) Fibrinolytic system of vascular endothelia cells. Role of plasminogen activator inhibitors. Haemostasis 18:328–341

    PubMed  CAS  Google Scholar 

  4. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ (1988) Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 12:5797–5803

    Google Scholar 

  5. Beutler B, Cerami A (1987) Cachectin: More than a tumor necrosis factor. N Engl J Med 316:379–385

    Article  PubMed  CAS  Google Scholar 

  6. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106–113

    Article  PubMed  CAS  Google Scholar 

  7. Dinarello CA (1988) Biology of interleukin 1. FASEB J 2:108–115

    PubMed  CAS  Google Scholar 

  8. Ishii H, Majerus PW (1985) Thrombomodulin is present in human plasma and urine. J Clin Invest 76:2178–2181

    Article  PubMed  CAS  Google Scholar 

  9. Moor KL, Esmon CT, Esmon NL (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159–165

    Google Scholar 

  10. Ishii H, Uchiyama H, Hiraishi S, Nakano M, Tubouchi J, Kazama M, Tanaka A (1989) Clinical significance of plasma thrombomodulin (in Japanese with English abstract). Rinsho byori (Clin Pathol) 37:266–271

    PubMed  CAS  Google Scholar 

  11. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH (1992) Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744–748

    Article  PubMed  CAS  Google Scholar 

  12. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN (1992) Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20:1090–1096

    PubMed  CAS  Google Scholar 

  13. Haeffner-Cavaillon N, Roussellier N, Ponzio O, Carreno MP, Laude M, Carpentier A, Kazatchkine MD (1989) Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 98:1100–1106

    PubMed  CAS  Google Scholar 

  14. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM (1992) Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 53:833–838

    Article  PubMed  CAS  Google Scholar 

  15. Giuliani R, Szwarcer E, Aquino EM, Palumbo G (1991) Fibrindependent fibrinolytic activity during extracorporeal circulation. Thromb Res 61:369–373

    Article  PubMed  CAS  Google Scholar 

  16. P⇘ramo JA, Rifon J, Llorens R, Casares J, Paloma MJ, Rocha E (1991) Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery. Haemostasis 21:58–64

    Google Scholar 

  17. Naito Y, Tamai S, Shingu K, Shindo K, Matui T, Segawa H, Nakai Y Mori K (1992) Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 77:426–431

    PubMed  CAS  Google Scholar 

  18. Sprengers ED, Kluft C (1987) Plasminogen activator inhibitors. Blood 69:381–387

    PubMed  CAS  Google Scholar 

  19. Kluithof EKO, Tran-Thang C, Bachmann F (1986) Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemostas 55:201–205

    Google Scholar 

  20. Gando S, Tedo I, Tujinaga H, Kubota M (1988) Serial changes of FPA and FPBβ15-42 during surgery with cardiopulmonary bypass (in Japanese with English abstract). Masui (Jpn J Anesthesiol) 37:541–545

    PubMed  CAS  Google Scholar 

  21. Movat HZ (1987) Tumor necrosis factor and interleukin-1; Role in acute inflammation and microvascular injury. J Lab Clin Med 110:668–681

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency and Critical Care Medicine, Sapporo City General Hospital, N1, W9, Chuo-ku, 060, Sapporo, Japan

    Satoshi Gando & Ichiro Tedo

Authors
  1. Satoshi Gando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ichiro Tedo
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Gando, S., Tedo, I. Fibrinolytic shutdown after cardiopulmonary bypass surgery is caused by circulating cytokines during operation, accompanied by endothelial injury. J Anesth 9, 17–21 (1995). https://doi.org/10.1007/BF02482029

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482029

Key words

Search

Navigation